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Hepatitis C virus (HCV) core protein constitutes a viral nucleocapsid and may possess multiple functions. In this study,
we demonstrated the homotypic interaction and multimerization of HCV core protein in vitro and in vivo. By using a yeast
two-hybrid system, we showed that the amino-terminal hydrophilic portion (amino acids 1–115) of the core protein could
interact with itself. Deletion analysis mapped the interacting domain within amino acid residues 36–91. The homotypic
interaction of the core protein was also confirmed by in vitro protein–protein blotting assay using the recombinant HCV
core proteins and by its binding to the glutathione S-transferase core fusion protein. The biological significance of the core
protein self-interactions was demonstrated by the detection of multimeric forms of the core protein in mammalian cells.
The domain responsible for multimerization was determined to be within the amino-terminal hydrophilic region (amino acids
1 – 115). Both the membrane-bound and the free core proteins exist in dimeric and multimeric forms, suggesting that
multimerization of the HCV core protein occurred at an early stage of viral assembly and that the multimer forms may be
involved in multiple functions of the core protein. q 1996 Academic Press, Inc.
INTRODUCTION The ribosome- and RNA-binding domains were mapped
to the amino-terminal region between amino acid resi-
Hepatitis C virus (HCV), a member of the Flaviviridae dues 1 and 75 of the core protein (Santolini et al., 1994).
family, is a positive-stranded RNA virus (Choo et al., 1991; HCV core protein has also been shown to suppress the
Kato et al., 1990; Takamizawa et al., 1991) which usually replication and gene expression of hepatitis B virus (HBV)
causes persistent infection, resulting in chronic hepatitis, (Shih et al., 1993). In addition, it has been shown to be
liver cirrhosis, and hepatocellular carcinoma (Aach et al., phosphorylated by protein kinase A and protein kinase
1991; Alter et al., 1992; Di Bisceglie et al., 1991; Kiyosawa C, and phosphorylation is essential for the HCV core
et al., 1990; Tassopoulos et al., 1992; Tremolada et al., protein to suppress HBV replication and gene expression
1991). The viral structural and nonstructural proteins are (Shih et al., 1995). The phosphorylation sites were
produced by cleavage of a large polyprotein precursor mapped to Ser-99 and Ser-116 but not Ser-53 (Shih et
by both host cell signal peptidases and viral proteinases al., 1995). Finally, HCV core protein activated human c-
(Hijikata et al., 1991; Grakoui et al., 1993). Among the myc, Rous sarcoma virus long terminal repeat (LTR), and
viral structural proteins, core protein, which is derived simian virus 40 (SV40) early promoters and suppressed
from the amino terminus of the polyprotein, likely forms the c-fos promoter and human immunodeficiency virus
the nucleocapsid of the virion because it is highly basic type 1 LTR activity (Ray et al., 1995). Taken together,
and similar in many biological properties to the nucleo- these results suggest that the HCV core protein is a
capsid proteins found in other flaviviruses (Grakoui et multifunctional protein.
al., 1993; Harada et al., 1991; Selby et al., 1993). The Nucleocapsid formation of virion particles probably in-
nucleotide and predicted amino acid sequences of the volves multimerization of core protein and its interaction
core protein genes are well conserved among different with viral RNA. The RNA-binding properties of HCV core
HCV isolates (Bukh et al., 1994). Recent studies have protein have been reported (Santolini et al., 1994; Hwang
demonstrated that HCV core protein bound to cell mem- et al., 1995). However, the possible multimerization prop-
branes both in vitro and in vivo and also bound the 60S erties have not been examined. Recent studies have
ribosomal subunit and RNA in vitro (Santolini et al., 1994). shown that core proteins of many different viruses can
oligomerize. For example, the gag proteins of the human
immunodeficiency virus, which include matrix, capsid,
1 To whom correspondence and reprint requests should be ad- and nucleocapsid proteins, have been shown by a yeast
dressed at Department of Molecular Microbiology and Immunology,
two-hybrid system to form homodimers; the sequenceUniversity of Southern California School of Medicine, 2011 Zonal Ave-
necessary for the multimerization was located at the car-nue, HMR-401, Los Angeles, CA 90033-1056. Fax: 213-342-9555. E-
mail: michlai@hsc.usc.edu. boxy termini of the nucleocapsid and capsid proteins
43
0042-6822/96 $18.00
Copyright q 1996 by Academic Press, Inc.
All rights of reproduction in any form reserved.
AID VY 7808 / 6a13$$$$$1 02-29-96 16:47:06 vira AP: Virology
44 MATSUMOTO ET AL.
(Luban et al., 1992; Franke et al., 1994). The core protein SV40 splicing donor and acceptor sequence into the re-
gion between the CMV promoter and the multiple cloningof HBV also forms a multimer via its carboxy-terminal
sequence; the truncation of this sequence affects capsid sites of pCDNA3. The full-length core gene of the HCV-
T sequence was cloned into the EcoRV site of pCMV,formation and encapsidation of HBV pregenomic RNA
(Beames and Lanford, 1993; Birnbaum and Nassal, 1990; yielding plasmid pCMV/core(1-191), which contains the
HCV core gene sequence under the control of the CMVZhou and Standring, 1992; Chang et al., 1994). Here we
report homotypic interaction and multimerization of HCV immediate–early promoter. Plasmids expressing the
truncation mutants of HCV core protein, pCMV/core(1-core protein in vitro and in vivo. This homotypic interac-
tion may be important for HCV assembly and other bio- 153) and pCMV/core(1-115), were generated by the same





The Saccharomyces cerevisiae strain PCY2 (Chevray
The HCV cDNA fragment representing the entire core
and Nathans, 1992) was grown in YPD (1% yeast extract,
protein-coding region (amino acids 1–191) of the HCV-
2% peptone, 2% dextrose) or synthetic minimal medium
T strain (Chen et al., 1992) was generated by polymerase
(0.67% yeast nitrogen base, 2% dextrose with appropriate
chain reaction (PCR) using two primers corresponding
auxotrophic supplements). Yeast was cotransformed
to the 5*- and 3*-ends of the core protein gene plus
with GAL4 DNA-binding-domain plasmids and GAL4 acti-
BamHI sites and was subcloned into the unique BamHI
vation plasmids by the lithium acetate method (Gietz et
site of the yeast plasmids pGBT9 and pGADGH (Clon-
al., 1992) and selected for leucine and tryptophan proto-
tech, Palo Alto, CA). The resulting plasmid pGBT9/
trophy. b-Galactosidase activity was assayed on nitrocel-
Core(1-191) and plasmid pGADGH/Core(1-191) encode
lulose filter replicas of yeast transformants. Filters were
the GAL4 DNA-binding domain fused to the full-length
placed in liquid nitrogen for 30 sec and incubated for 8
HCV core protein and a GAL4 activation domain–HCV
hr in buffer containing 4 mM 5-bromo-4-chloro-3-indolyl-
core fusion protein, respectively. Deletion mutants of
b-D-galactoside (X-gal). Positive interactions were indi-
HCV core proteins were also generated by similar meth-
cated by the appearance of blue colonies.
ods using specific primers corresponding to different
regions of the core genes. The resulting plasmids, GST fusion protein binding assay
pGBT9/Core(1-115), pGBT9/Core(1-91), pGBT9/Core(1-
25), pGBT9/Core(36-115), and pGBT9/Core(36-91), en- Plasmid pGEX-HCV-core, which expresses GST–HCV
core fusion protein, was grown in E. coli strain BL21(DE3)code a GAL4 DNA-binding domain fused to the different
regions of HCV core protein. pGADGH/Core(1-115) en- (Novagen, Madison, WI) and induced with 1 mM isopro-
pylthio-b-D-galactoside (IPTG). Bacteria were pelleted 3codes a GAL4 activation domain fused to amino acids
1–115 of the core protein. hr after IPTG induction, washed with phosphate-buffered
saline (PBS), and resuspended in lysis buffer (1% TritonTo construct the plasmid expressing HCV core protein
in Escherichia coli, a PCR-generated BamHI fragment X-100 in PBS). The suspended bacteria were sonicated
on ice for 40 sec and pelleted by brief centrifugation.containing the full-length core gene of HCV-T strain was
cloned into the BamHI site of pGEX-4T-1 (Pharmacia, Supernatants were incubated with glutathione–Sepha-
rose 4B beads (Pharmacia) overnight at 47. The beadsUppsala, Sweden). The resulting plasmid, pGEX-HCV-
core, encodes a full-length core protein fused to a gluta- were collected by brief centrifugation in a microfuge and
washed four times in 1% Triton X-100 in PBS and oncethione S-transferase (GST) protein.
For construction of the plasmid used for in vitro tran- in PBS. Plasmid pCDNA3/core was transcribed in vitro
using T7 RNA polymerase, and the resulting RNA wasscription, a BamHI fragment containing the full-length
core sequence of the HCV-T strain was cloned into the translated in a rabbit reticulocyte lysate with [35S]-
methionine. Approximately equal amounts, as judged byBamHI site of plasmid pCDNA3 (Invitrogen, San Diego,
CA). The resulting plasmid, pCDNA3/core, encodes the Coomassie blue staining, of GST or GST–HCV core fu-
sion protein on glutathione–Sepharose beads were incu-full-length HCV core protein (a.a. 1–191) under the cyto-
megalovirus (CMV) immediate–early promoter and T7 bated with the [35S]methionine-labeled proteins in incu-
bation buffer [40 mM HEPES (pH 7.5), 100 mM KCl, 0.1%promoter.
For expression of HCV core protein in mammalian Nonidet P-40, and 20 mM 2-mercaptoethanol] for 2 hr at
47 and then rinsed four times in incubation buffer. Thecells, vector pCMV, which is a derivative of pCDNA3,
was used. To construct pCMV, a NruI–HindIII fragment beads were boiled in Laemmli sample buffer (Laemmli,
1970), and the supernatants were analyzed by electro-was removed from pCDNA3 and replaced with the
EcoRI– NotI fragment of pCMVb (Clontech), resulting in phoresis on 15% polyacrylamide gel containing SDS. Af-
terwards, the gel was dried and autoradiographed.the removal of the T7 promoter and the insertion of the
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Far-Western protein–protein blotting material pelleted by the centrifugation was resuspended
in 0.8 ml LSB and designated as the final fraction of the
Recombinant HCV core protein expressed in E. coli gradient. All fractions were diluted with 4 ml of LSB and
(Lo et al., 1995) and hepatitis delta antigen (of hepatitis recentrifuged in a Beckman SW55Ti rotor at 46,000 rpm
delta virus) expressed by recombinant baculovirus for 90 min at 47, and the resulting pellets were dissolved
(Hwang et al., 1992) were lysed by Laemmli sample in LSB.
buffer, separated by SDS–PAGE on a 15% polyacryl-
amide gel, and stained with Coomassie brilliant blue or Cross-linking of proteins by glutaraldehyde
electrotransferred to a nitrocellulose membrane. The
Proteins in cellular lysates or collected from sucrosemembrane was washed with buffer A [10 mM HEPES –
gradients were incubated with 0.01% glutaraldehydeKOH (pH 7.5), 60 mM KCl, 1 mM EDTA and 1 mM 2-
(Sigma, St. Louis, MO) in LSB for various time periods atmercaptoethanol] and incubated with 6 M guanidine HCl
room temperature. The reaction was stopped by additionfor 15 min at 47 and then sequentially with 3 M, 1.5 M,
of an equal volume of 21 Laemmli sample buffer (Laem-0.75 M, 0.38 M, 0.19 M, and 0.09 M guanidine HCl for 5
mli, 1970). After heating at 807 for 10 min, the cross-min each to renature the proteins. The membrane was
linked proteins were separated by SDS–PAGE and elec-subsequently blocked for 1 hr at 47 with 5% nonfat dry
trotransferred to nitrocellulose membrane for immu-milk in buffer A containing 0.05% Nonidet P-40. The in
noblot analysis.vitro translated, [35S]methionine-labeled HCV core pro-
tein was incubated with the membrane in buffer A con-
Immunoblot detection of HCV core proteintaining 3% nonfat dry milk and 0.05% Nonidet P-40 over-
night at 47. Unbound proteins were removed by washing The proteins blotted onto nitrocellulose membrane
three times with buffer A containing 1% nonfat dry milk were first treated with 5% nonfat milk in PBS for 60 min
and 0.05% Nonidet P-40. Protein binding was detected and then incubated with rabbit polyclonal anti-HCV core
by autoradiography. antibody (diluted 1:500) for 2 hr at room temperature.
After three washes in PBS, the blots were incubated with
DNA transfections 125I-labeled protein A for 2 hr at room temperature. The
membrane was washed, and bound antibody was de-COS 7 cells were used for DNA transfection. The cells
tected by autoradiography.were seeded in 10-cm dishes and cultured at 377 under
5% CO2 for 24 hr in Dulbecco’s modified Eagle’s medium
RESULTScontaining 10% fetal calf serum. After medium changes,
cells were transfected with 20 mg plasmid DNA by the Detection of the homotypic interaction of HCV core
calcium phosphate precipitation method (Chen and protein in the yeast two-hybrid system
Okayama, 1987). The medium was changed after 14 hr
To determine whether HCV core protein can undergoof incubation, and cells were collected 48 hr later. Cells
homotypic interaction, we first employed the yeast two-were washed with ice-cold PBS twice and harvested.
hybrid system (Fields and Song, 1989; Chien et al., 1991).
For this purpose, HCV core protein was fused to the CMembrane flotation analysis
termini of the DNA-binding domain or the activation do-
main of GAL4 in yeast plasmids pGBT9 and pGADGH,The membrane flotation method was performed as de-
scribed by Sanderson et al. (1993). Cells transfected with respectively. We first tested four combinations of plas-
mids, which encoded different lengths of HCV core pro-DNA were suspended in 0.5 ml hypotonic lysis buffer (10
mM Tris HCl, pH 7.5, 10 mM KCl, 5 mM MgCl2) and tein [either full-length (a.a. 1–191) or hydrophilic domain
only (a.a. 1–115)] (Fig. 1). The appearance of blue colo-incubated on ice for 10 min before disruption of the cells
by passage through a 26-gauge hypodermic needle 15 nies was scored as a positive reaction. The results
showed that the full-length HCV core protein (a.a. 1–times. Unbroken cells and nuclei were removed by cen-
trifugation at 1000 g for 5 min, and the resulting superna- 191) fused with either the activation or the DNA-binding
domain of GAL4 did not yield any positive colonies. How-tant was subjected to fractionation by the membrane
flotation method as described (Sanderson et al., 1993). ever, when both the activation domain and the DNA-
binding domain contained a partial HCV core sequenceBriefly, 0.5-ml aliquots of lysates were dispersed into 2
ml of 72% (wt/wt) sucrose in low-salt buffer (LSB) (50 mM from a.a. 1–115, which represents the hydrophilic portion
of the core protein, positive colonies were detected (Ta-Tris–HCl, pH 7.5, 25 mM KCl, 5 mM MgCl2) and overlaid
with 2.5 ml of 55% (wt/wt) sucrose in LSB and 0.6 ml of ble 1). Control plasmids expressing only a partial GAL4
protein without the HCV core sequence did not induce10% (wt/wt) sucrose in LSB. Sucrose gradients were then
centrifuged in a Beckman SW55Ti rotor at 47 for 12 hr at b-galactosidase. This result suggests that HCV core pro-
teins can interact with each other through their hydro-38,000 rpm. After centrifugation, 0.8-ml fractions were
collected successively from the top of the gradient. Any philic domains, amino acids 1–115. The failure of the
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FIG. 1. Schematic representation of the deletion mutants of HCV core protein used in this study. The hydrophilicity plot of the core protein was
derived using the MacVector program (IBI, New Haven, CT). The positions of the amino acid residues encoded by each construct are indicated
above the boxes.
full-length HCV core proteins to interact in the yeast two- pGADGH/core(1-115) into yeast and assayed for b-gal
induction. Results showed that the truncated core pro-hybrid system was probably due to the presence of the
hydrophobic domain, which may interfere with the nu- teins containing either a.a. 1–91 or a.a. 36–115, but not
a.a. 1–25, could interact with core a.a. 1–115 (Table 1),clear transport of the fusion proteins in the yeast, thus
invalidating this assay. suggesting that the homotypic interacting domain of the
core proteins is located within a.a. 36–91. However, a.a.
Mapping of the protein-interacting domain of HCV 36–91 induced only a weak, though reproducible, inter-
core protein action (Table 1), suggesting that neighboring regions of
the core protein around a.a. 36–91 also contribute to theTo further define the domain of the HCV core protein
homotypic interaction of HCV core protein.responsible for its homotypic interactions, we con-
structed several plasmids encoding a GAL4 DNA-binding
domain fused with various truncated core proteins (Fig. Homotypic interaction of HCV core protein in vitro
1). The resulting plasmids were cotransformed with
Since the homotypic interaction of core proteins de-
tected in the yeast two-hybrid system could have been
TABLE 1 mediated by a yeast protein, we performed in vitro bio-
chemical binding assays to determine whether the HCVHomotypic Interaction of HCV Core Protein Detected
by the Yeast Two-Hybrid System core protein can self-interact directly. We constructed a
plasmid, pGEX-HCV-core, which expressed a full-length
b-Galactosidase inductiona core protein fused to GST protein in E. coli. The GST –
HCV core fusion protein was bound to glutathione –Activation domain hybrid
Sepharose 4B beads and incubated with the in vitroDNA-binding
domain hybrid a.a. 1–191 a.a. 1–115 Vector alone translated, [35S]methionine-labeled HCV core protein.
The bound protein was analyzed by SDS–PAGE. Figure
a.a. 1–191 0/33 0/110 0/80 2 shows that 35S-labeled HCV core bound GST–HCVa.a. 1–115 0/58 11/14 0/54
core fusion protein but not GST. This result indicated thata.a. 1–91 n.t.b 36/52 0/71
HCV core protein can interact with itself directly. It isa.a. 36–115 n.t. 14/50 0/105
a.a. 1–25 n.t. 0/37 0/56 interesting to note that while the full-length core protein
a.a. 36–91 n.t. 3/110 0/95 did not induce b-galactosidase activity in the yeast two-
Vector alone n.t. 0/118 0/86
hybrid system, the GST fusion protein containing the full-
length core protein did interact with itself in the directa No. of positive/no. of scored clones.
b n.t., not tested. binding assay. Thus, the hydrophobic sequence of the
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ment caused the appearance of a dimeric-sized (40-kDa)
HCV core protein (Fig. 4A). As the treatment time was
increased, an additional band of approximately 60 kDa
appeared, which may represent core protein trimers. Cor-
respondingly, the amounts of monomer protein (20 kDa)
decreased as the length of treatment was increased.
During treatments lasting more than 10 min, the amounts
of 40- and 60-kDa proteins did not increase any further.
However, there was a continuous increase in the amount
of the proteins which did not enter the gel and a corre-
sponding reduction of the monomer protein, suggesting
the formation of bigger protein complexes. Since lysates
contained numerous cellular proteins in addition to theFIG. 2. Homotypic interaction of HCV core protein in vitro. Approxi-
HCV core protein, the detection of the discrete speciesmately equal amounts of GST or GST–HCV core fusion protein on
glutathione–Sepharose beads were incubated with the in vitro trans- of high-molecular-weight forms of the core proteins after
lated, [35S]methionine-labeled HCV core protein. The beads were boiled cross-linking is indicative of the formation of specific
in Laemmli sample buffer, and the supernatants were analyzed by complexes involving distinct protein species. The 40-kDaelectrophoresis on 15% polyacrylamide gel containing SDS. Probe: in
protein likely represents the dimeric form of HCV corevitro translated HCV core protein. The full-length HCV core protein is
protein (20 kDa), while the 60-kDa protein correspondsindicated by an arrow.
to the trimer form. The protein complex at the top of the
gel may represent multimer complexes. These results
core protein did not interfere with its homotypic interac- thus indicate that HCV core protein forms multimers in
tion in vitro. vivo. The dimers and trimers detected probably represent
We have further studied the homotypic interaction be- the intermediates of multimeric complex formation. When
tween HCV core proteins by a Far-Western protein blot- truncated HCV core proteins were expressed, similar re-
ting assay. In this assay, E. coli lysate containing the sults were obtained (Figs. 4B and 4C). Without glutaralde-
recombinant full-length HCV core protein was separated hyde cross-linking, HCV core proteins a.a. 1–153 and 1–
by SDS–PAGE and transferred to nitrocellulose mem- 115 existed as proteins of 18 and 16 kDa, respectively.
brane. Proteins on the membrane were denatured, rena- After glutaraldehyde cross-linking, protein bands of di-
tured, and incubated with 35S-labeled, in vitro translated meric size, and possibly also trimeric size, were de-
HCV core protein. Hepatitis delta antigen (HDAg) of hep- tected. Interestingly, the N-terminal hydrophilic portion
atitis delta virus (HDV) was used as a control. Figure 3 (a.a. 1–115) of the core protein formed mostly multimeric
shows that in vitro translated HCV core protein bound to forms; very little dimeric or trimeric form was detected
the recombinant HCV core protein, but not HDAg. Since
both HDAg and HCV core protein are highly basic nucleo-
capsid proteins (Chang et al., 1988; Bukh et al., 1994),
and their sizes and biochemical properties are similar,
this result suggests that the homotypic interaction of HCV
core protein requires a specific sequence, which cannot
be substituted by basic amino acid residues of other
proteins. These results combined indicate that HCV core
protein can undergo specific homotypic interaction di-
rectly.
Multimerization of HCV core protein in mammalian
cells
To demonstrate the biological significance of the ho-
motypic interaction of HCV core protein, we determined
FIG. 3. Homotypic interaction of HCV core protein in Far-Western
whether this protein exists as multimers when it is ex- protein blotting assay. E. coli-expressed HCV core protein and baculovi-
pressed in mammalian cells. We transfected COS 7 cells rus-expressed hepatitis delta antigen were separated by SDS–PAGE
on a 15% polyacrylamide gel, and stained with Coomassie brilliant bluewith expression plasmids which contained the full-length
(A) or electrotransferred to a nitrocellulose membrane (B). The proteinsor truncated core protein-coding region under the CMV
on the membrane were denatured and renatured and incubated withimmediate–early promoter (Fig. 1). The proteins in the
in vitro translated, [35S]methionine-labeled HCV core protein. Protein
cellular lysates were cross-linked with glutaraldehyde, binding was detected by autoradiography (B). M: molecular size marker
and the HCV core protein was detected by immunoblot- (in kilodaltons). HCV core is indicated by a solid arrow, and HDV HDAg
is indicated by an open arrow.ting. The results showed that the glutaraldehyde treat-
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(Santolini et al., 1994; Lanford et al., 1993), we wanted
to examine whether multimerization of the protein in vivo
requires the presence of the membrane. We separated
the cellular lysates by a membrane flotation method
(Sanderson et al., 1993) into membrane and soluble frac-
tions. HCV core protein in each fraction was detected by
immunoblotting. Figure 5A shows the results with the
full-length core protein. A majority of the core protein
was recovered in the membrane fraction (Fig. 5A, lane 1),
while only a small amount of the protein was recovered in
the membrane-free form (fractions 4, 5, and 6). Interest-
ingly, some of the core protein associated with the mem-
brane already existed as dimeric and multimeric forms,
even without glutaraldehyde cross-linking (Fig. 5A, lane
1). After glutaraldehyde treatment, the intensity of the
dimeric (40 kDa) and multimeric forms increased (Fig.
5B). The dimeric and multimeric species were seen with
both the membrane-associated and the membrane-free
fractions, although the latter represented only a small
fraction of the core protein. In contrast, most of the trun-
cated forms (a.a. 1–153 and 1–115) of the core proteins
were membrane-free (Figs. 5C and 5E, lanes 4, 5, and 6).
After glutaraldehyde treatments, the dimer and multimer
forms were detected in both the membrane-associated
and the membrane-free fractions (Figs. 5D and 5F). In
the case of a.a. 1–115 protein, most of the cross-linked
proteins were in multimeric form (Fig. 5F), rather than
the dimer form, consistent with the previous finding (Fig.
4). These results indicate that the multimerization of the
core protein occurred in both membrane-associated and
membrane-free forms in mammalian cells.
DISCUSSION
FIG. 4. Kinetic studies of glutaraldehyde cross-linking of HCV core The data presented in this report demonstrated the
protein expressed in COS 7 cells. COS 7 cells were transfected with homotypic interaction of HCV core protein in vitro and in
expression plasmids pCMV/core(1-191) (A), pCMV/core(1-153) (B), or vivo. Since the primary function of viral core proteinspCMV/core(1-115) (C). Cells were harvested 48 hr after transfection.
usually is to provide a protective shell for the viral ge-Cell lysates were treated with 0.01% glutaraldehyde for 1*, 3*, 6*, 10*,
nome inside, the ability of core proteins to multimerize15*, 21*, or 30* at room temperature. HCV core protein was separated
on SDS-containing 12.5% polyacrylamide gel and detected by immu- to form a nucleocapsid would be an indispensable prop-
noblotting using a polyclonal antibody against HCV core. 0: without erty of this structural protein. Indeed, in many viruses,
cross-linking. 1*, 3*, 6*, 10*, 15*, 21*, and 30* indicate lengths (in min) nucleocapsid proteins have been shown to dimerize andof glutaraldehyde treatment. Mock: transfected with vector plasmid.
multimerize (Luban et al., 1992; Franke et al., 1994;Arrows indicate monomer, dimer, and trimer forms of HCV core protein,
Beames and Lanford, 1993; Birnbaum and Nassal, 1990;respectively, from the bottom. Top arrow indicates multimer which did
not enter the gels. Zhou and Standring, 1992; Chang et al., 1994). HCV core
protein would be expected to have similar properties.
(Fig. 4C). These findings indicate that the N-terminal hy- However, the structure of HCV nucleocapsid is still poorly
drophilic region of the core protein is responsible for its understood. It is not known how the HCV core proteins
multimerization. This result is consistent with the obser- assemble into a nucleocapsid structure. The finding in
vation using the yeast two-hybrid system, in which HCV this report that this protein forms multimers in vitro and in
core protein interacted with itself through the middle re- vivo provides a structural basis for the viral nucleocapsid
gion of the N-terminal hydrophilic domain. formation of HCV.
Subcellular localization of the multimeric forms of Our data showed that the hydrophilic domain (a.a. 1–
HCV core protein 115) is mainly responsible for the homotypic interaction
of HCV core protein in vitro and in vivo. This conclusionSince most of the HCV core protein has been shown
to be associated with the endoplasmic reticulum (ER) was reached from the studies in the yeast two-hybrid
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FIG. 5. Membrane flotation analysis of HCV core proteins expressed in COS 7 cells. COS 7 cells were transfected with expression plasmids,
pCMV/core(1-191) (A and B), pCMV/core(1-153) (C and D), or pCMV/core(1-115) (E and F), and cells were harvested 48 hr after transfection. Cell
lysates were fractionated by equilibrium sucrose gradient centrifugation and fractions were collected from the top of the gradient. The pelleted
proteins were resuspended in buffer and designated as fraction 6. The remaining sucrose fractions were numbered from 1 to 5 in the order of top
to bottom (light to heavy) fractions. Recovered proteins were analyzed either directly without glutaraldehyde treatment (A, C, and E) or after treatment
with 0.01% glutaraldehyde for 15 min (B, D, and F). Solid arrows indicate monomer and open arrows indicate dimer. Mock: transfected with vector
plasmid.
system, in vitro protein– protein binding assays, and the is outside the domain responsible for the suppression
of HBV gene expression (a.a. 101–122) (Shih et al., 1993).protein cross-linking experiments in mammalian cells.
This hydrophilic domain is rich in basic amino acid resi- However, a.a. 36–91 alone appear to be insufficient for
efficient protein binding; the neighboring sequencesdues and is very conserved among different HCV isolates
(Bukh et al., 1994). The protein–protein interaction of likely contributed to the homotypic interaction. It is not
clear whether the partial overlapping of the protein-inter-HCV core protein appears to require a specific amino
acid sequence, inasmuch as HDAg, which has biochemi- acting and RNA-binding domains of HCV core protein
have any functional significance. In this regard, it hascal properties and sizes similar to those of HCV core
protein, did not interact with the latter. The precise amino been shown that the multimerization domain of NS1 pro-
tein of influenza virus overlaps its RNA-binding domainacid residues involved in the homotypic interactions re-
main to be determined. The yeast two-hybrid system ten- (Nemeroff et al., 1995) and that the multimerization of
Rev protein of human immunodeficiency virus 1 also in-tatively mapped the homotypic interacting domain at a.a.
36–91, which overlaps the ribosome-binding and RNA- volves its RNA-binding domain and adjacent sequences
(Olsen et al., 1990; Zapp et al., 1991). One potential out-binding domains (a.a. 1– 75) (Santolini et al., 1994), but
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come of this overlap of functional domains is that multi- We could resolve only two of the discrete oligomers,
including dimer and trimer, under our experimental con-merization of core protein may alter the conformation of
RNA-binding domain, or vice versa, to facilitate RNA – ditions; the large aggregate of HCV core protein which
did not enter gels may represent larger multimer com-protein interactions in virus assembly. It would be inter-
esting to know whether homotypic interaction is required plexes. The multimeric form was the major cross-linked
protein species derived from the truncated HCV corefor other functions of the core protein. The homotypic
interacting domain also includes a purported phosphory- protein that contains only the hydrophilic domain (Figs.
4 and 5). It is not clear what the size of this large complexlation site, Ser-53, but not Ser-99 or Ser-116 (Shih et al.,
1995). It is not clear whether phosphorylation can affect is. Nevertheless, these large complexes are probably the
precursor to nucleocapsid formation. Further studies onthe homotypic interaction of the core protein.
The role of the hydrophobic domain (a.a. 116–191) in the properties of this multimer protein species will likely
yield insights into the mechanism of virus assembly.the homotypic interaction of HCV core protein remains
to be investigated. We found that the presence of this
domain interfered with protein interaction in the yeast
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